| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 12, 2018Virtual Press Office and PR Newswire: General Trade show news
Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation NASHVILLE, Tenn., Feb. 12, 2018 /PRNewswire/ -- InsCorp,...
-
Feb 12, 2018Virtual Press Office and PR Newswire: General Trade show news
Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation. EXTON, Pa., Feb. 12, 2018 /PRNewswire/ -- First...
-
Feb 12, 2018Virtual Press Office and PR Newswire: General Trade show news
Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation FRESNO Calif., Feb. 12, 2018 /PRNewswire/ -- Communities...
-
Feb 12, 2018Virtual Press Office and PR Newswire: General Trade show news
Santen Inc. today announced that the topline results from the Phase I/II study of DE-122 (carotuximab) for refractory wet age-related macular degeneration (AMD) were presented at the 15th Annual...
-
Feb 12, 2018Virtual Press Office and PR Newswire: General Trade show news
Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associate companies) today announced that 12...
